GS

Geethanath Sairam

Active Director Director DIN 09492928
DIN 09492928 First appointment Feb 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Geethanath Sairam

Data last updated:

Geethanath Sairam is a Director at Mri-Access Private Limited (since 2022). The company operates in Healthcare.

DIN 09492928
Primary Designation Director
Industry Healthcare
First Appointment 04 Feb 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mri-Access Private Limited U33100AP2022FTC120727
Director04 Feb 20222022Active

Board colleagues of Geethanath Sairam

NameDINCompanyDesignation
Christopher Grant Rose09492927Mri-Access Private LimitedDirector
Suresh Marpu09242135Mri-Access Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Mri-Access Private Limited
Premium access

Shareholding and investment profile for Geethanath Sairam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geethanath Sairam

Geethanath Sairam currently holds 1 directorship: Mri-Access Private Limited (Director, since 04 Feb 2022).

Geethanath Sairam was first appointed on 04 Feb 2022 as Director at Mri-Access Private Limited.

The current boards of Geethanath Sairam's companies include Christopher Grant Rose (Mri-Access Private Limited), Suresh Marpu (Mri-Access Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available